KMT2A and acute myeloid leukemia: Therefore, it is crucial to understand the mechanisms underlying the pathogenesis and chemotherapy resistance of AML, such as MLL-rearranged AML, and identify potential new therapeutic targets that can suppress AML or improve the response to the currently existing chemotherapies.